1. Academic Validation
  2. Study on the mechanism of heterogeneous tumor-associated macrophages in three subtypes of breast cancer through the integration of single-cell RNA sequencing and in vitro experiments

Study on the mechanism of heterogeneous tumor-associated macrophages in three subtypes of breast cancer through the integration of single-cell RNA sequencing and in vitro experiments

  • Mol Biol Rep. 2024 Jun 1;51(1):720. doi: 10.1007/s11033-024-09665-5.
Yan Yuan 1 2 Shu Zhang 3 4 Jian Huang 5
Affiliations

Affiliations

  • 1 Center for Clinical Laboratories, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China.
  • 2 Department of Basic Clinical Laboratory Medicine, School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, 550004, China.
  • 3 Center for Clinical Laboratories, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China. zhangshu10042003@163.com.
  • 4 Department of Basic Clinical Laboratory Medicine, School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, 550004, China. zhangshu10042003@163.com.
  • 5 Center for Clinical Laboratories, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China. huangjian810309@gmc.edu.cn.
Abstract

Background: Tumor-associated macrophages (TAM) exert a significant influence on the progression and heterogeneity of various subtypes of breast Cancer (BRCA). However, the roles of heterogeneous TAM within BRCA subtypes remain unclear. Therefore, this study sought to elucidate the role of TAM across the following three BRCA subtypes: triple-negative breast Cancer, luminal, and HER2.

Materials and methods: This investigation aimed to delineate the variations in marker genes, drug sensitivity, and cellular communication among TAM across the three BRCA subtypes. We identified specific ligand-receptor (L-R) pairs and downstream mechanisms regulated by VEGFA-VEGFR1, SPP1-CD44, and SPP1-ITGB1 L-R pairs. Experimental verification of these pairs was conducted by co-culturing macrophages with three subtypes of BRCA cells.

Results: Our findings reveal the heterogeneity of macrophages within the three BRCA subtypes, evidenced by variations in marker gene expression, composition, and functional characteristics. Notably, heterogeneous TAM were found to promote invasive migration and epithelial-mesenchymal transition (EMT) in MDA-MB-231, MCF-7, and SKBR3 cells, activating NF-κB pathway via p38 MAPK, TGF-β1, and Akt, respectively, through distinct VEGFA-VEGFR1, SPP1-CD44, and SPP1-ITGB1 L-R pairs. Inhibition of these specific L-R pairs effectively reversed EMT, migration, and invasion of each Cancer cells. Furthermore, we observed a correlation between ligand gene expression and TAM sensitivity to Anticancer drugs, suggesting a potential strategy for optimizing personalized treatment guidance.

Conclusion: Our study highlights the capacity of heterogeneous TAM to modulate biological functions via distinct pathways mediated by specific L-R pairs within diverse BRCA subtypes. This study might provide insights into precision immunotherapy of different subtypes of BRCA.

Keywords

Breast cancer; Cellular communication; Heterogeneity; Single-cell RNA sequencing; Tumor microenvironment; Tumor-associated macrophages.

Figures
Products